Influenza A virus hemagglutinin conserved epitopes (IAV HA conserved epitopes)

Hemagglutinin (HA) is the primary surface glycoprotein of the influenza A virus, essential for viral attachment to host sialic acid receptors and subsequent membrane fusion. While the globular head of HA undergoes frequent antigenic drift to evade the immune system, certain regions—most notably the HA stem (or stalk) and the receptor-binding site—remain highly conserved across various influenza subtypes. These conserved epitopes are the focus of intense research for the development of universal influenza vaccines and broadly neutralizing monoclonal antibodies (bnAbs) that can provide cross-protection against seasonal and pandemic-potential strains. Most antibodies targeting the HA stem function by sterically hindering the structural rearrangements necessary for fusion within the endosome. Therapeutic strategies often involve 'headless' HA constructs or chimeric proteins designed to redirect the immune response away from the immunodominant variable head toward these stable, conserved regions. Successful targeting of these epitopes could eliminate the need for annual vaccine reformulations and provide a critical defense against emerging zoonotic influenza threats.

Other names

Hemagglutinin stalk domainHemagglutinin stem domainHA conserved regionsBroadly neutralizing epitopes of HAUniversal influenza vaccine target

Broadly neutralizing antibodies (bnAbs) bind to conserved epitopes, primarily in the HA stem, to inhibit the pH-triggered conformational change required for viral-host membrane fusion, thereby preventing viral genome release into the cytoplasm.